drugset / Trial / NCT04421287

Clinical Study on the Effect of Zhenyuan Capsule on Cardiopulmonary Function in Patients With SCAD

NCT04421287 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

A randomized, double-blind, placebo trial was adopted, and cardiopulmonary exercise load test (CPET) was used to detect peak oxygen uptake (PeakVO2) and exercise metabolic equivalent (METs) to confirm the clinical effect of Zhenyuan capsule on improving cardiopulmonary endurance in patients with coronary heart disease of qi deficiency and blood stasis.

Timeline

Start
2020-06-01
Primary completion
2021-07-01
Completion
2021-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Zhenyuan capsule Unknown 0.25 g —